Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice
- 16 March 2015
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 33 (4) , 402-407
Abstract
Identifying T-cell receptors (TCRs) that bind tumor-associated antigens (TAAs) with optimal affinity is a key bottleneck in the development of adoptive T-cell therapy of cancer. TAAs are unmutated self proteins, and T cells bearing high-affinity TCRs specific for such antigens are commonly deleted in the thymus. To identify optimal-affinity TCRs, we generated antigen-negative humanized mice with a diverse human TCR repertoire restricted to the human leukocyte antigen (HLA) A*02:01 (ref. 3). These mice were immunized with human TAAs, for which they are not tolerant, allowing induction of CD8⁺ T cells with optimal-affinity TCRs. We isolate TCRs specific for the cancer/testis (CT) antigen MAGE-A1 (ref. 4) and show that two of them have an anti-tumor effect in vivo. By comparison, human-derived TCRs have lower affinity and do not mediate substantial therapeutic effects. We also identify optimal-affinity TCRs specific for the CT antigen NY-ESO. Our humanized mouse model provides a useful tool for the generation of optimal-affinity TCRs for T-cell therapy.Keywords
This publication has 47 references indexed in Scilit:
- NY‐ESO‐1 antigen‐reactive T cell receptors exhibit diverse therapeutic capabilityInternational Journal of Cancer, 2012
- Long-term Persistence of CD4+ but Rapid Disappearance of CD8+ T Cells Expressing an MHC Class I-restricted TCR of Nanomolar AffinityMolecular Therapy, 2012
- Development of Human Anti-Murine T-Cell Receptor Antibodies in Both Responding and Nonresponding Patients Enrolled in TCR Gene Therapy TrialsClinical Cancer Research, 2010
- A Single Peptide–MHC Complex Positively Selects a Diverse and Specific CD8 T Cell RepertoireScience, 2009
- Germline-encoded amino acids in the αβ T-cell receptor control thymic selectionNature, 2009
- Characterization of Genetically Modified T-Cell Receptors that Recognize the CEA:691-699 Peptide in the Context of HLA-A2.1 on Human Colorectal Cancer CellsClinical Cancer Research, 2008
- Adoptive T cell therapy for cancer in the clinicJournal of Clinical Investigation, 2007
- Enhanced Antitumor Activity of T Cells Engineered to Express T-Cell Receptors with a Second Disulfide BondCancer Research, 2007
- ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteinsNucleic Acids Research, 2006
- Plat-E: an efficient and stable system for transient packaging of retrovirusesGene Therapy, 2000